Promimic AB - Asset Resilience Ratio
Promimic AB (PRO) has an Asset Resilience Ratio of 8.62% as of December 2022. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2019–2022)
This chart shows how Promimic AB's Asset Resilience Ratio has changed over time. Check PRO strategic assets to equity ratio to assess the company's strategic physical and investment asset allocation.
Liquid Assets Composition Over Time
This chart breaks down Promimic AB's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see market cap of Promimic AB.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | Skr0.00 | 0% |
| Short-term Investments | Skr8.00 Million | 8.62% |
| Total Liquid Assets | Skr8.00 Million | 8.62% |
Asset Resilience Insights
- Limited Liquidity: Promimic AB maintains only 8.62% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
Promimic AB Industry Peers by Asset Resilience Ratio
Compare Promimic AB's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Cochlear Ltd
AU:COH |
Medical Devices | 9.76% |
|
Novocure Ltd
NASDAQ:NVCR |
Medical Devices | 43.72% |
|
Sinocare Inc
SHE:300298 |
Medical Devices | 3.53% |
|
L&C Bio Co. Ltd
KQ:290650 |
Medical Devices | 2.14% |
|
Shanghai ZJ Bio-Tech Co. Ltd. A
SHG:688317 |
Medical Devices | 10.88% |
|
Bactiguard Holding AB (publ)
ST:BACTI-B |
Medical Devices | 8.12% |
|
Oncosil Medical Ltd
AU:OSL |
Medical Devices | 0.00% |
|
Anteris Technologies Global Corp
AU:AVR |
Medical Devices | 33.27% |
Annual Asset Resilience Ratio for Promimic AB (2019–2022)
The table below shows the annual Asset Resilience Ratio data for Promimic AB.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2022-12-31 | 8.62% | Skr8.00 Million ≈ $860.93K |
Skr92.77 Million ≈ $9.98 Million |
+10.93pp |
| 2021-12-31 | -2.31% | Skr-743.00K ≈ $-79.96K |
Skr32.16 Million ≈ $3.46 Million |
-14.60pp |
| 2019-12-31 | 12.29% | Skr4.00 Million ≈ $430.48K |
Skr32.56 Million ≈ $3.50 Million |
-- |
About Promimic AB
Promimic AB (publ) manufactures, markets, and sells biomaterials for improved osseointegration for orthopedic and dental implants markets. It offers HAnano surface technology that combines various properties that are known to improve osseointegration into one unique surface modification. The company was incorporated in 2004 and is based in Mölndal, Sweden.